OPERAND Pharmaceuticals III LTD

General

Total Cases2

Active Cases1

Patents--

CourtsD. New Jersey E.D. Wisconsin

TypeOperating Company

Elite Ratings

--

--

--

--

Ratings

Experience

Grade

Trend

DCT

--

--

--

PTAB

--

--

--

CAFC

--

--

--

Analytics

Cases

Litigated Patents

Ratings Trends

Recent Dockets

Entered	Case	Description
03/25/24	Endo Ventures Ltd v. Nexus Pharma Inc 2:23-CV-00299 ( E.D. WI )	JUDGMENT signed by Deputy Clerk on 3/25/24. (cc: all counsel)(jad)
03/25/24	Endo Ventures Ltd v. Nexus Pharma Inc 2:23-CV-00299 ( E.D. WI )	ORDER signed by Judge Brett H Ludwig on 3/25/24 that Nexus's Motion to Dismiss the First Amended Complaint 32 is GRANTED. The complaint is dismissed for lack of personal jurisdiction. Nexus's Motion to Dismiss the complaint 18 is DENIED as moot. The Motion to Restrict Document 30 is GRANTED. (cc: all counsel)(jad)
09/25/23	Endo Ventures Ltd v. Nexus Pharma Inc 2:23-CV-00299 ( E.D. WI )	NOTICE of Appearance by Julianne M Hartzell on behalf of Nexus Pharmaceuticals Inc. Attorney(s) appearing: Julianne M. Hartzell; Thomas R. Burns; Isha S. Shah (Hartzell, Julianne)
08/11/23	Nexus Pharma Inc v. Nevakar Inc 1:22-CV-05683 ( D. NJ )	LETTER ORDER Granting Plaintiff's 137 request to amend the Court's 132 Order to allow Plaintiff to amend its Complaint by August 10, 2023; Clerk shall amend the docket and caption of this action to substitute "Nexus Pharmaceuticals, LLC" in place of "Nexus Pharmaceuticals, Inc.". Signed by Magistrate Judge Sharon A. King on 8/11/2023. (mag) (Entered: 08/11/2023)
08/10/23	Nexus Pharma Inc v. Nevakar Inc 1:22-CV-05683 ( D. NJ )	AMENDED COMPLAINT against ENDO VENTURES UNLIMITED COMPANY, NEVAKAR INJECTABLES, INC., NEVAKAR, INC., OPERAND PHARMACEUTICALS III LIMITED, PAR PHARMACEUTICAL, INC., PAR STERILE PRODUCTS, LLC, filed by NEXUS PHARMACEUTICALS, LLC.(QUINN, JUSTIN) (Entered: 08/10/2023)
08/09/23	Nexus Pharma Inc v. Nevakar Inc 1:22-CV-05683 ( D. NJ )	Letter from Justin T. Quinn, Esq. to the Honorable Sharon A. King, U.S.M.J re 132 Order on Motion to Amend/Correct, 136 Order, 135 Letter. (QUINN, JUSTIN) (Entered: 08/09/2023)
08/04/23	Endo Ventures Ltd v. Nexus Pharma Inc 2:23-CV-00299 ( E.D. WI )	REPLY BRIEF in Support filed by Nexus Pharmaceuticals Inc re 32 MOTION to Dismiss First Amended Complaint . (Wilbert, Johanna)
08/04/23	Nexus Pharma Inc v. Nevakar Inc 1:22-CV-05683 ( D. NJ )	LETTER ORDER Granting Plaintiff's 135 request for an extension of the amended pleading deadline; the deadline is extended from August 3, 2023 to August 10, 2023. Signed by Magistrate Judge Sharon A. King on 8/4/2023. (mag) (Entered: 08/04/2023)
08/03/23	Nexus Pharma Inc v. Nevakar Inc 1:22-CV-05683 ( D. NJ )	Letter from Justin T. Quinn, Esq. to the Honorable Sharon A. King, U.S.M.J. requesting extension re 132 Order on Motion to Amend/Correct,. (QUINN, JUSTIN) (Entered: 08/03/2023)
07/31/23	Nexus Pharma Inc v. Nevakar Inc 1:22-CV-05683 ( D. NJ )	Set Deadlines as to 134 Consent MOTION to Seal Portions of the Par Defendants' Motion to Amend/Correct Case Caption, Substitute Parties, and File Amended Answer. Motion set for 8/21/2023 before Magistrate Judge Sharon A. King. Unless otherwise directed by the Court, this motion will be decided on the papers and no appearances are required. Note that this is an automatically generated message from the Clerk`s Office and does not supersede any previous or subsequent orders from the Court. (mag) (Entered: 07/31/2023) Set Deadlines as to 134 Consent MOTION to Seal Portions of the Par Defendants' Motion to Amend/Correct Case Caption, Substitute Parties, and File Amended Answer. Motion set for 8/21/2023 before Magistrate Judge Sharon A. King. Unless otherwise directed by the Court, this motion will be decided on the papers and no appearances are required. Note that this is an automatically generated message from the Clerk`s Office and does not supersede any previous or subsequent orders from the Court. (mag) (Entered: 07/31/2023)